CROI 2014: Conference On Retroviruses And Opportunistic Infections
|
|
- Jason Thompson
- 6 years ago
- Views:
Transcription
1 CROI 2014: Conference On Retroviruses nd Opportunistic Infections TUESY, MRCH 4 Investigator Time Session Location Title Oral Poster Other uthors Rosenberg, Eli 0-3 Prevention and Epidemiology: Evolving Trends allroom Race and ge isparities in HIV Incidence and Prevalence mong MSM in tlanta, G 38 Patrick S. Sullivan, Colleen F. Kelley, Travis H. Sanchez, Nicole Luisi, Carlos del Rio, Paula F. Frew Spearman, Paul avid Knowlton, Caitlin McGary, Colleen Mylvaganam, Geetha H., Mirko Wang, Charlene T2 Restriction allroom T3 Heart Failure, Cardiac Steatosis, Room 304 P- 1 SMH1 P- 1 It s ll bout the Gut P- 1 It s ll bout the Gut P- C2 Immune ctivation and Pathogenesis P- F2 ynamics of Persistent and Rebound HIV iscussion Leader epression re Risk for Incident Heart Failure mong Veterans 726 Vpx Mediated egradation of SMH1 oes Not Render HSCs More Permissive To Lentiviral Gene Transfer 169 aek Kim CCR6+ and C161+ C4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques 313 SIV Vaccine Controllers Prevent berrant ccumulation of Follicular C4 T Cells in Rectal Mucosa 314 Interleukin- 21 Reduces Residual Immune ctivation in RT- Treated SIV- Infected Rhesus Macaques 270L Effects of CCR5- Δ32 Heterozygosity On HIV- 1 Reservoir Size and Immune ctivation 391 Luca Micci, Emily S. Ryan, Guido Silvestri, ftab. nsari, Mirko Vijayakumar Velu, Jung- Joo Hong, Shanmugalakshmi Sadagopal, Suefen Kwa, Rahul asu, enton Lawson, Francois Villinger, Rama R. mara Luca Micci, Emily Ryan, Colleen McGary, Sara Paganini, Guido Silvestri, Francois Villinger, Mirko
2 CROI 2014: Conference On Retroviruses nd Opportunistic Infections Investigator Time Session Location Title Oral Poster Other uthors avid P- P1 Heart Failure, Cardiac Steatosis, epression re Risk for Incident Heart Failure mong Veterans 726 del Rio, Carlos Goswami, Neela. Hanley, Krisztina P- W4 Cascade of Care P- W2 Cascade of Care, Linkage, and Retention P- S1 Reproductive Hormones in Women: Impact On Risk and arrier ysfunction Trends in Cascade of Care in the Eastern European Country of Georgia: Correlation etween Community Variables Linkage To Care and Viral Suppression, tlanta, G 988 epot- Medroxyprogesterone cetate oes Not Increase Genital SHIV Shedding in Macaques 844 Sharoda asgupta, Patrick Sullivan, Carlos del Rio, Travis Sanchez WENESY, MRCH 5 Investigator Time Session Location Title Oral Poster Other uthors Ofotokun, Igho Hanley, Krisztina McGary, Colleen 0-7 Randomized Controlled Trials and ntiretroviral Resistance allroom /C T10 Reproductive Hormones in Women: Impact On Risk and arrier ysfunction Room 311 T9 Gut and Immune ctivation Room 312 Efficacy and Tolerability of tazanavir, Raltegravir, or arunavir With FTC/Tenofovir: CTG Jeffrey L. Lennox epot- Medroxyprogesterone cetate oes Not Increase Genital SHIV Shedding in Macaques 844 CCR6+ and C161+ C4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques 313 Luca Micci, Emily S. Ryan, Guido Silvestri, ftab. nsari, Mirko
3 CROI 2014: Conference On Retroviruses nd Opportunistic Infections Investigator Time Session Location Title Oral Poster Other uthors Cartwright, Emily K. Cribbs, Sushma K. Mavigner, Maud Rogers, Kenneth avid avid Kilembe, William avid P- 4 Non- Pathogenic vs Pathogenic Hosts P- F5 What and Where Is the Reservoir? P- F6 What Can We Learn From one Marrow Transplantation? P- 4 Non- Pathogenic vs Pathogenic Hosts P- N3 HCV: Prognosis and Impact of Treatment Including Liver Transplantation P- P4 Risk and Incidence: MI and Stroke P- W5 cute Infection P- Q4 Lung isease ivergent C4+ T Memory Stem Cell ynamics in Pathogenic and Nonpathogenic SIV Infections 325 Healthy HIV- Infected Subjects Harbor HIV in lveolar Macrophages, Which Can Impair Lung Function 410 Targeting SIV Reservoirs via utologous Hematopoietic Stem Cell Transplant in Rhesus Macaques 416 Colleen McGary, arbara Cervasi, enton Lawson, Steven E. osinger, Thomas H. Vanderford, Mirko, nn M. Chahroudi, Guido Silvestri avid M. Guidot, Lou nn rown, Jeffrey Lennox enjamin Watkins, enton O. Lawson, nn Chahroudi, Leslie S. Kean, Guido Silvestri ifferential TCR ctivation and TRIL Regulation insooty Mangabeys and Rhesus Macaques 324 Francois Villinger Level of lcohol Use and dvanced Hepatic Fibrosis in HIV- Infected and Uninfected Patients 651 HIV Infection, Cardiovascular Risk Factor Profile, and Risk for cute Myocardial Infarction 736 ssociation etween Number of cute Retroviral Symptoms and Extended High Viremia by HIV- 1 Subtype 1003 Susan llen, Eric Hunter HIV Infection and Related iomarkers re Independent Risk for Radiographic Emphysema 775 Cherry Wongtrakool
4 CROI 2014: Conference On Retroviruses nd Opportunistic Infections Investigator Time Session Location Title Oral Poster Other uthors Rosebush, Julia C. P- U5 Complications of HIV and RT in Children and dolescents Preclinical therosclerosis in Eastern frica: Results From a Pediatric Ethiopian Cohort 917 llison Eckard Wongtrakool, Cherry P- Q4 Lung isease ssociation of HIV Infection and Immune ctivation With ecline in Lung Function 774 THURSY, MRCH 6 Investigator Time Session Location Title Oral Poster Other uthors osinger, Steven Mavigner, Maud avid avid nderson, lbert M. 0-9 Interferon and ntibody at the Interface of Innate and daptive Immunity To HIV Room 312 T14 What We Learn From one Marrow Transplants Room 312 T12 Pulmonary Complications of HIV Infection allroom T12 Pulmonary Complications of HIV Infection P- G8 CNS Inflammation, Immune ctivation, and HN iomarkers allroom Type I Interferon Signaling Is Critical for Early Control of Immune System amage 128 Targeting SIV Reservoirs via utologous Hematopoietic Stem Cell Transplant in Rhesus Macaques 416 ssociation of HIV Infection and Immune ctivation With enjamin Watkins, enton O. Lawson, nn Chahroudi, Leslie S. Kean, Guido Silvestri ecline in Lung Function 774 Cherry Wongtrakool HIV Infection and Related iomarkers re Independent Risk for Radiographic Emphysema 775 CSF iomarkers Correlate With Magnetic Resonance Spectroscopy Metabolites uring HIV isease 487
5 CROI 2014: Conference On Retroviruses nd Opportunistic Infections Investigator Time Session Location Title Oral Poster Other uthors erdeyn, Cynthia P- 6 HIV Entry Early Non- Mac- Tropic HIV- 1 R5 Envs Efficiently Trans- Infect T Cells and Infect Ectocervices 193 Hayes, Timothy Neigh, Gretchen N. utler, Javed Ofotokun, Igho avid Kelley, Colleen F. Sullivan, Patrick P- 6 New Themes in Host Control P- 6 New Themes in Host Control P- N8 HCV- Related Outcomes: Cardiac and Non- Liver P- P5 ntiretroviral Therapy, Lipids, and CV P- N9 HV and HV P- W9 Transmission/Risk P- W9 Transmission/Risk Effect of C8 epletion On C4+ T- Cell Subsets in SIV Infection 332 Low Social Rank Prior To SIV or SHIV Infection ssociates With Higher Viral Load in Chronic Infection 333 HCV Viremia and the Risk of cute Myocardial Infarction at Various Lipid Levels 685 arunavir or tazanavir vs Raltegravir Lipid Changes re Unlinked To Ritonavir Exposure: CTG Jeffrey Lennox Isolated Hepatitis Core ntibody Is ssociated With dvanced Hepatic Fibrosis 695 The Effect of Sexually Transmitted Infections On HIV Incidence mong MSM in tlanta, G 1028 Prevalence and Predictors of HIV isclosure mong dults Receiving Care in the United States 1033 Steven E. osinger, nkita Chowdhury, enton O. Lawson, arbara Cervasi, Kiran Gill, Mirko, Guido Silvestri Timothy Hayes, Ronald Trible, Thomas H. Vanderford, iane G. Carnathan, Constance S. Harrell, Kirk Easley, Mirko, Guido Silvestri dam S. Vaughan, Nicole Luisi, Travis Sanchez, Paula Frew, Carlos del Rio, Patrick S. Sullivan, Eli S. Rosenberg
CTLA-4-expressing CD4 T cells are critical contributors to SIV viral persistence
IAS 2015 Towards an HIV Cure symposium Vancouver CTLA-4-expressing CD4 T cells are critical contributors to SIV viral persistence Colleen McGary Paiardini lab Emory University HIV reservoir prevents eradication
More informationCombined IL-21 and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques
Combined and IFNα treatment limits inflammation and delay viral rebound in ART-treated, SIV-infected macaques Mirko Paiardini Associate Professor, Emory University School of Medicine Yerkes National Primate
More informationInterleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques
Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques Luca Micci, Emory University Emily S. Ryan, Emory University Rémi Fromentin, Université de Montréal Steven
More informationHow can new technologies and social media improve HIV prevention for gay and bisexual men?
How can new technologies and social media improve HIV prevention for gay and bisexual men? May 8th, 2015 Patrick S. Sullivan, PhD Rollins School of Public Health Presentation Plan HIV in MSM Atlanta: A
More informationand Future Directions
Involve[men]t PrEP, Health Disparities, A Study of Race and Age in HIV/STI Incidence and Prevalence Among MSM in Atlanta, and Future Directions GA: 2009-2014 Patrick Sullivan, DVM, PhD Rollins School of
More informationRecent Insights into HIV Pathogenesis and Treatment: Towards a Cure
Recent Insights into HIV Pathogenesis and Treatment: Towards a Cure Deborah Persaud, M.D. Associate Professor Department of Pediatrics Division of Infectious Diseases Johns Hopkins University School of
More informationCopyright information:
Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors Kiran Mir-Hudgeons, Emory University Maud Mavigner,
More informationWith over 20 drugs and several viable regimens, the mo6vated pa6ent with life- long access to therapy can control HIV indefinitely, elimina6ng the
Towards an HIV Cure Steven G. Deeks, MD Professor of Medicine in Residence HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 22, 2013 1 With over 20 drugs and several
More informationCROI 2016 Review: Immunology and Vaccines
Frontier AIDS Education and Training Center CROI 2016 Review: Immunology and Vaccines Meena Ramchandani MD MPH Acting Instructor, University of Washington March 2016 This presentation is intended for educational
More informationHIV Pathogenesis and Natural History. Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco
HIV Pathogenesis and Natural History Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco Learning Objectives Describe key features of HIV pathogenesis and natural history
More informationShiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School
CTLs, Natural Killers and NKTs 1 Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTL inducing tumor apoptosis 3 Lecture outline CD8 + Cytotoxic T lymphocytes (CTL) Activation/differentiation
More informationCD40L-Adjuvanted DNA/MVA SIV Vaccine Enhances Protection. Against Neutralization Resistant Mucosal SIV Infection
JVI Accepted Manuscript Posted Online 4 February 2015 J. Virol. doi:10.1128/jvi.03527-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 CD40L-Adjuvanted DNA/MVA SIV Vaccine
More informationTarget Cell Availability, Rather than Breast Milk Factors, Dictates Mother-to-Infant Transmission of SIV in Sooty Mangabeys and Rhesus Macaques
Target Cell Availability, Rather than Breast Milk Factors, Dictates Mother-to-Infant Transmission of SIV in Sooty Mangabeys and Rhesus Macaques Ann Chahroudi, Emory University Emily Cartwright, Emory University
More informationIAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB
IAS Conference Vienna 18 th to 23 rd July 2010 overview Paul Clift King s College Hospital/UK-CAB Overall Conference I c. 25,000 participants Covers everything HIV-related Several Pre-conferences: Faith,
More informationCorrection. E3366 PNAS April 18, 2017 vol. 114 no
orrection IMMUNOLOGY ND INFLMMTION orrection for Dynamics of SIV-specific XR5+ D8 T cells during chronic SIV infection, by Geetha H. Mylvaganam, Daniel Rios, Hadia M. bdelaal, Smita Iyer, Gregory Tharp,
More informationPD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Brief report Related Commentary, page 1611 PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques Ravi Dyavar Shetty, 1 Vijayakumar Velu,
More informationHIV/HCV co-infected patients should be prioritised for HCV treatment. Sanjay Bhagani Royal Free Hospital/UCL London
HIV/HCV co-infected patients should be prioritised for HCV treatment Sanjay Bhagani Royal Free Hospital/UCL London Also requires other resources What should a prioritisation process Life-saving at this
More informationPage 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
More informationThe Geography of Infectious Diseases Related to the Opioid Epidemic. Patrick Sullivan, DVM, PhD Emory University March 12, 2018
The Geography of Infectious Diseases Related to the Opioid Epidemic Patrick Sullivan, DVM, PhD Emory University March 12, 2018 Presentation Outline The importance of infectious diseases in the opioid epidemic
More informationHIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense
Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD
More informationEradication of HIV infection Not in my lifetime? or Just around the Corner? Michael M. Lederman, MD
Eradication of HIV infection Not in my lifetime? or Just around the Corner? Michael M. Lederman, MD Conflicts of Interest The pending clinical trials discussed here are funded by grant awards from Gilead
More informationPerspective HIV Infection: Advances Toward a Cure
Perspective HIV Infection: dvances Toward a Cure chieving cure of HIV infection requires eliminating all replication-competent virus from the reservoir of latently infected cells or completely inhibiting
More informationA VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART
BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adaptive immune response biologic response modifiers and, 735 737 S-Adenosylmethionine (SAMe) for hepatitis, 825 826 Albinterferon for hepatitis,
More informationAIDS free generation. Bob Colebunders Institute of Tropical Medicine
AIDS free generation Bob Colebunders Institute of Tropical Medicine Why this optimism? Rapid scale-up of antiretroviral therapy Treatment can prevent new infections Expanded coverage of programmes to prevent
More informationthe Office of Research Application Portal: Materials to submit:
Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due
More informationProfessor Jeffery Lennox
BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions Professor Jeffery Lennox Emory University School of Medicine Atlanta, Georgia, USA 9-10 October 2014, Queen Elizabeth II Conference Centre,
More informationUnderstanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute
Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought
More informationcure research HIV & AIDS
Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may
More informationMID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.
Life Cycle Diagnosis and Pathogenesis Scott M. Hammer, M.D. -1 Virion Entry Life Cycle of Entry -1 virion -1 Virus virion envelope Cell membrane receptor RELEASE OF PROGENY VIRUS REVERSE Co- TRANSCRIPTION
More informationAIDS at 25. Epidemiology and Clinical Management MID 37
AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and
More informationProgesterone Increases are Associated With HIV Susceptibility Factors in Women
Progesterone Increases are Associated With HIV Susceptibility Factors in Women Alison Y Swaims 1, Tammy Evans-Strickfaden 1, L Davis Lupo 1, Alfredo Aguirre 2, Anandi Sheth 2, Igho Ofotokun 2, Clyde E
More informationHIV Antibody Characterization for Reservoir and Eradication Studies. Michael Busch, Sheila Keating, Chris Pilcher, Steve Deeks
HIV Antibody Characterization for Reservoir and Eradication Studies Michael Busch, Sheila Keating, Chris Pilcher, Steve Deeks Blood Systems Research Institute University of California San Francisco, CA
More informationVenue-Based and On-line Sampling. Patrick S. Sullivan, DVM, PhD Department of Epidemiology January 18, 2018
Venue-Based and On-line Sampling Patrick S. Sullivan, DVM, PhD Department of Epidemiology January 18, 2018 Source: Beyrer, Mayer, Sanchez, Sullivan, Guest eds. Lancet 2012. Diagnoses of HIV Infection
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationHarvard University Affiliated Abstract Presentations at CROI
BOSTON, MASSACHUSETTS February 22 25, 2016 Harvard University Affiliated Abstract Presentations at CROI This table represents abstracts reported to the Harvard University Center for AIDS Research by members
More informationHIV life cycle revisited: What s new in basic science? Theresa Rossouw
HIV life cycle revisited: What s new in basic science? Theresa Rossouw Outline of the Presentation Lifecycle overview New drugs & therapies Cell entry Co-receptor binding Attachment Keeping it Simple
More informationEXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE
EXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE CECILE DELILLE LAHIRI, M.D, M.SC ASSISTANT PROFESSOR DIVISION OF INFECTIOUS DISEASES MAY 18, 2016 OUTLINE Describe discrepancy between
More informationMicro 301 HIV/AIDS. Since its discovery 31 years ago 12/3/ Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people
Micro 301 HIV/AIDS Shiu-Lok Hu hus@uw.edu December 3, 2012 Since its discovery 31 years ago Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people In 2011 34.0 million [31.4 35.9 million]
More informationTherapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome
30 1, 1, 2, 3 1. ( ), 201508; 2., 200040; 3., 200032 : ( AIDS) ( HIV) 20 90,,,,,, AIDS, CD4 + T ( CTL), HIV, : ; ; Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome
More informationMEDICAL CONDITIONS AND THEIR IMPACT ON DENTAL CARE
MEDICAL CONDITIONS AND THEIR IMPACT ON DENTAL CARE Preface James R. Hupp xiii Ischemic Heart Disease: Dental Management Considerations 483 James R. Hupp Ischemic heart disease (IHD) is a common problem.
More informationRationale for therapy at PHI
Rationale for therapy at PHI Immunological: Interfere with pathogenesis Preserve HIV-specific CD4+ T-help Reduce T-cell activation Virological: Prevent or reduce seeding of reservoirs Affect viral set
More informationCytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,
Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under
More informationPost-Sexual Exposure Prophylaxis (npep)
Projeto Praça Onze Universidade Federal do Rio de Janeiro Post-Sexual Exposure Prophylaxis (npep) Mauro Schechter Principal Investigator, Projeto Praça Onze Professor of Infectious Diseases Universidade
More informationAIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37
AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children
More informationOver thousands of years, species-specific
T1 Natural SIV Hosts: Showing AIDS the Door Ann Chahroudi, 1,2 Steven E. Bosinger, 2 Thomas H. Vanderford, 2 Mirko Paiardini, 2,3 * Guido Silvestri 2,3 * Many species of African nonhuman primates are naturally
More informationHIV Prevention in Clinical Care Settings
NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV Prevention in Clinical Care Settings Jeanne Marrazzo, MD, MPH Professor, Division of Allergy and Infectious Diseases University of Washington HIV Prevention
More informationHerpes virus co-factors in HIV infection
Herpes virus co-factors in HIV infection Dr Jane Deayton Barts and the London Queen Mary School of Medicine Introduction Herpes viruses very common and often coexist with HIV Establish life-long latent
More informationMacrophages and Pulmonary Pathogenesis in Young and Aged SIV-Infected Rhesus Macaques
Macrophages and Pulmonary Pathogenesis in Young and Aged SIV-Infected Rhesus Macaques Yanhui CAI (Jenny) Oct. 20 th, 2014 Division of Immunology Tulane National Primate Research Center Covington, LA 1
More informationBody & Soul. Research update, 25 October 2016
Body & Soul Research update, 25 October 2016 Updates from BHIVA conference on... Cure breakthrough or not? Long acting retrovirals what do they offer? When to start treatment asap post diagnosis? Media
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationViral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection
Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection Koen Van Rompay California National Primate Research Center University of California Davis Outline Introduction
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More informationThis graph displays the natural history of the HIV disease. During acute infection there is high levels of HIV RNA in plasma, and CD4 s counts
1 2 This graph displays the natural history of the HIV disease. During acute infection there is high levels of HIV RNA in plasma, and CD4 s counts decreased. This period of acute infection or serocnversion
More informationHIV-1 Dual Infection and Neurocognitive Impairment
HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral
More informationRepeat Pregnancies and HIV Care Engagement among Postpartum HIV-infected Women in Atlanta, Georgia,
Repeat Pregnancies and HIV Care Engagement among Postpartum HIV-infected Women in Atlanta, Georgia, 2011-2015 Anandi N. Sheth, Christina M. Meade, Martina Badell, Susan A. Davis, Stephanie Hackett, Joy
More informationFrequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia
Frequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia 8 th International Workshop on HIV Transmission Principles of Intervention Barcelona,
More informationHIV Life Cycle & Genetics
HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in
More informationManagement of Severe Primary HIV Infection
Management of Severe Primary HIV Infection Martin Fisher Brighton and Sussex University Hospitals Outline What is severe PHI? How frequent is severe PHI? Is this occurring more frequently? Is severe PHI
More informationReport Back from CROI 2010
Report Back from CROI 2010 Conference on Retroviruses and Opportunistic Infections Edwin Charlebois, MPH PhD Associate Professor of Medicine Department of Medicine University of California, San Francisco
More informationHIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital
HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per
More informationCHANGES IN GENITAL TRACT HIV TARGET CELLS WITH THREE PROGESTIN- BASED CONTRACEPTIVES
CHANGES IN GENITAL TRACT HIV TARGET CELLS WITH THREE PROGESTIN- BASED CONTRACEPTIVES Lisa B. Haddad 1, Alison Swaims Kohlmeier 2, Richard E. Haaland 2, Nakita L. Brown 3, L. Davis Lupo 2, Christina B.
More informationWhat is the place of the monoclonal antibodies in the clinic?
What is the place of the monoclonal antibodies in the clinic? Dr Julià Blanco 2018/04/26 DISCLOSURE AlbaJuna Therapeutics, S.L. ANTIBODIES IN HIV INFECTION. ANTIVIRAL (NEUTRALIZING) ACTIVITY env THE BROADLY
More informationAntibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center
Antibody Dependent Cellular Cytotxic activity: Past and Future Guido Ferrari, M.D. Duke University Medical Center Mechanism of Antibody Dependent Cellular Cytotoxicity (ADCC) ADCC Effector Cells (NK, monocytes/macrophages,
More informationApproaching a Cure Daniel R. Kuritzkes, MD
Approaching a Cure Daniel R. Kuritzkes, MD Division of Infectious Diseases Brigham and Women s Hospital Harvard Medical School Disclosures The speaker is a consultant and/or has received speaking honoraria
More informationWomen and PrEP: What are local health departments doing?
Women and PrEP: What are local health departments doing? Gretchen Weiss, MPH Director of HIV, STI, & Viral Hepatitis National Association of County and City Health Officials (NACCHO) Illinois HIV/STD Conference
More informationDr Jintanat Ananworanich
BHIVA AUTUMN CONFERENCE 2014 Including CHIVA Parallel Sessions Dr Jintanat Ananworanich US Military HIV Research Program in Bethesda Maryland, USA 9-10 October 2014, Queen Elizabeth II Conference Centre,
More informationDiscovery of HIV and Early Findings
Discovery of HIV and Early Findings Jay A. Levy, M.D. Professor of Medicine Director, Laboratory for Tumor and AIDS Virus Research University of California, San Francisco, CA Major Epidemics of the World
More informationAnalysis of the In Vivo Turnover of CD4+T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys
Analysis of the In Vivo Turnover of CD4+T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys Alexandra M. Ortiz, Emory University Diane G. Carnathan, Emory University Joana Yu, Emory University Katherine
More informationPreclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps
Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps NIAID Workshop, May 22-23, 2018 Nancy L. Haigwood, Oregon Health & Science University Mississippi baby case brought
More informationInves&gación básica y curación del VIH-1
Inves&gación básica y curación del VIH-1 Javier Mar&nez-Picado 24 th Conference on Retroviruses and Opportunis6c Infec6ons UNIVERSITAT DE VIC Empezamos bien cart: How Early is Early Enough? Sáez-Cirion
More informationUpdate on HIV-HCV Epidemiology and Natural History
Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,
More informationInves)gación básica y curación del VIH- 1
Inves)gación básica y curación del VIH- 1 Javier Mar)nez- Picado (jmpicado@irsicaixa.es) 23 rd Conference on Retroviruses and Opportunis5c Infec5ons February 22-25, 2016 Boston, Massachuse8s UNIVERSITAT
More informationTrends in Malignancies Among HIV-Infected Patients. Roger Bedimo, MD, MS VA North Texas Health Care System UT Southwestern Medical Center
Trends in Malignancies Among HIV-Infected Patients Roger Bedimo, MD, MS VA North Texas Health Care System UT Southwestern Medical Center Denver, April 2011 Learning Objectives At the conclusion of this
More informationMortality and Causes of Death Among HIV/HCV Co-Infected Persons in the Eastern European Country of Georgia
Mortality and Causes of Death Among HIV/HCV Co-Infected Persons in the Eastern European Country of Georgia Akaki Abutidze, 1 Natalia Bolokadze, 1 Nino Rukhadze, 1 Natia Dvali, 1 Lali Sharvadze, 1,2 Tengiz
More informationInformation, inspiration and advocacy for people with HIV/AIDS and hepatitis C
Information, inspiration and advocacy for people with HIV/AIDS and hepatitis C p1 p5 p6 p7 HIV CARE NEWS New drugs: dolutegravir, MK-1439, cenicriviroc, and HIV and heart health. HIV PrEP NEWS Disappointing
More informationHS161 MIDTERM 3/24/04
HS161 MIDTERM 3/24/04 Instructions. Select the best response in each instance. For T/F questions, answer a for true and b for false. On Part A, please use a TE2000 scantron to record your answers. Use
More informationMicrobiology 507. Immune Response to Pathogens. Topics in Molecular Pathogenesis and Immunology. Zakaria Hmama, PhD UBC - Department of Medicine
Microbiology 507 Topics in Molecular Pathogenesis and Immunology Immune Response to Pathogens Zakaria Hmama, PhD UBC - Department of Medicine October 2012 ecture 1 Mechanisms of HIV pathogenesis 1- History
More informationAppendix E1. Epidemiology
Appendix E1 Epidemiology Viruses are the most frequent cause of human infectious diseases and are responsible for a spectrum of illnesses ranging from trivial colds to fatal immunoimpairment caused by
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationUsing Modeling to Set Programma2c Goals for HIV Preven2on in MSM. Patrick S. Sullivan, DVM, PhD Department of Epidemiology April 10, 2018
Using Modeling to Set Programma2c Goals for HIV Preven2on in MSM Patrick S. Sullivan, DVM, PhD Department of Epidemiology April 10, 2018 Source: Beyrer, Mayer, Sanchez, Sullivan, Guest eds. Lancet 2012.
More informationOR: Steps you can take in the clinic to prevent HIV infections
Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute
More informationThe potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies
The potential role of PD-1/PD-L1 blockade in HIV Remission and Cure Strategies Stephen Mason Director, Discovery Virology Bristol-Myers Squibb Community Cure Workshop 2015 Sunday, Feb 22, 2015 Seattle,
More informationThe Role of B Cell Follicles in HIV Replication and Persistence
The Role of B Cell ollicles in HIV Replication and Persistence Elizabeth Connick, M.D. Professor of Medicine Chief, Division of Infectious Diseases University of Arizona July 17, 2016 IAS 2016 Towards
More informationAREAS OF CONCENTRATION
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
More informationAntiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis
Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis Francesca Calascibetta, Emory University Luca Micci, Emory University Diane Carnathan,
More informationSupplementary Materials
1 Supplementary Materials Rotger et al. Table S1A: Demographic characteristics of study participants. VNP RP EC CP (n=6) (n=66) (n=9) (n=5) Male gender, n(%) 5 (83) 54 (82) 5 (56) 3 (60) White ethnicity,
More informationImmune Activation: Impact on Outcomes Peter W. Hunt, MD. Associate Professor of Medicine University of California San Francisco
Immune Activation: Impact on Outcomes Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco 10y Decreased Life Expectancy in Older HIV+ Adults in Modern ART Era ~9y shorter
More informationEstablishment and Targeting of the Viral Reservoir in Rhesus Monkeys
Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys Dan H. Barouch, M.D., Ph.D. Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT,
More informationRole of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
Velu et al. Retrovirology (2015) 12:14 DOI 10.1186/s12977-015-0144-x REVIEW Open Access Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options Vijayakumar Velu 1,2*, Ravi
More informationHIV AND INFLAMMATION: A NEW THREAT
HIV AND INFLAMMATION: A NEW THREAT KAP ANNUAL SCIENTIFIC CONFERENC MAY 2013 DR JOSEPH ALUOCH FRCP,EBS Basic Components of the Immune System Immunology: cells and tissues involved in recognizing and attacking
More informationHIV viral load testing in the era of ART. Christian Noah Labor Lademannbogen, Hamburg
HIV viral load testing in the era of ART Christian Noah Labor Lademannbogen, Hamburg 1 Life expectancy of patients on ART Data from the UK Collaborative HIV Cohort (UK CHIC) Requirements: Early diagnosis
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationThe Immune System. A macrophage. ! Functions of the Immune System. ! Types of Immune Responses. ! Organization of the Immune System
The Immune System! Functions of the Immune System! Types of Immune Responses! Organization of the Immune System! Innate Defense Mechanisms! Acquired Defense Mechanisms! Applied Immunology A macrophage
More informationAre we targeting the right HIV determinants?
QuickTime et un décompresseur TIFF (non compressé) sont requis pour visionner cette image. AIDS Vaccine 2009 October 22 nd 2009 - Paris Are we targeting the right HIV determinants? Françoise BARRÉ-SINOUSSI
More informationProfessor Jonathan Weber
HIV/AIDS at 30: Back to the Future BHIVA / Wellcome Trust Multidisciplinary Event to mark World AIDS Day 2011 British HIV Association (BHIVA) 2011 HIV/AIDS at 30: Back to the Future BHIVA / Wellcome Trust
More informationHIV and the immune system linked to heart disease in women
CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. HIV and the immune system linked to heart disease in women 26 September 2013 The widespread availability of potent combination anti-hiv
More informationSUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish
SUPPLEMENTARY INFOATION Divergent TLR7/9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS-virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford,
More information45. Female HIV Acquisition per Sex Act is Elevated in Late Pregnancy and Postpartum Renee Heffron, University of Washington, Seattle, WA, US
PRESS CONFERENCE SCHEDULE Conference on Retroviruses and Opportunistic Infections/CROI 2018 This press conference may be viewed live at https://zoom.us/j/408375781 or accessed by phone toll-free from the
More information